BioAtla Q2 EPS $(0.75) Misses $(0.62) Estimate
Portfolio Pulse from vinayak@benzinga.com
BioAtla (NASDAQ:BCAB) reported Q2 losses of $(0.75) per share, missing the analyst consensus estimate of $(0.62) by 20.97 percent. This is a 2.6 percent increase over losses of $(0.77) per share from the same period last year.
August 04, 2023 | 10:36 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
BioAtla's Q2 earnings missed analyst estimates by 20.97%, which could negatively impact the stock price in the short term.
BioAtla's Q2 earnings per share were lower than expected, missing analyst estimates by 20.97%. This could lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100